Meningococcal Disease Completed Phase 3 Trials for Bordetella pertussis pertactin antigen (DB10789)

Also known as: Meningococcal infection, unspecified / Meningococcal infectious disease (disorder) / Meningococcal infection / Unspecified meningococcal infection / Meningococcal Infections / Neisseria meningitidis infection NOS

DBCOND0033309 (Meningococcal Disease)Completed3 IdentifierTitlePurposeDrugs
NCT01642589Safety and Immunogenicity Study for Use of Menactra® Versus Adacel® in Subjects 11 to 55 Years of Age in South KoreaPrevention
NCT01000311A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 MonthsPrevention